Document is current
Any future updates will be listed below
-
Authors
Moiseyenko, Anastasiya
Antonello, Giacomo
Schonhoff, Aubrey M.
Boktor, Joseph C.
Long, Kaelyn
Dirks, Blake
Oguienko, Anastasiya D.
Winnett, Alexander Viloria
Simpson, Patrick
Daeizadeh, Dorsa
Ismagilov, Rustem F.
Krajmalnik-Brown, Rosa
Segata, Nicola
Waldron, Levi D.
Mazmanian, Sarkis K.
-
Funding
Funding for this research was provided by:
Jacobs Institute for Molecular Engineering for Medicine
Beckman Institute at Caltech
Aligning Science Across Parkinson's (ASAP-020495; ASAP-000375)
Heritage Medical Research Institute
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 30 January 2026
First Online: 5 March 2026
Competing interests
: S.K.M. is a founder and board member of Vertero Therapeutics and has equity in Nuanced Health and Seed Health. A.M. and S.K.M. hold a patent (US20240066074A1) on the use of Faecalibacterium prausnitzii and Prevotella histicola for the treatment of PD and have a pending application (US patent application 63/883,383) for the use of Faecalibacterium prausnitzii as a treatment for PD. The other authors do not have a competing interest.
